The pandemic legacy of antimicrobial resistance in the USA

Estimating antimicrobial resistance burden in Europe—what are the next steps?

Controlling the spread of vancomycin-resistant enterococci. Is active screening worthwhile?

Position Statement on Tobacco Exposures in Children and Families

Controversies in airway management of COVID-19 patients: updated information and international expert consensus recommendations

Testing the Asymptomatic Pre-Surgical Population for Severe Acute Respiratory Syndrome Coronavirus 2

Superficial surgical site infection postdischarge surveillance

Time To Get Serious About Infection Prevention in the ICU

Commentary

Notes from the Field: Planting, Nurturing, and Watching Things Grow

Reported maternal-to-fetal rates of primary cytomegalovirus (CMV) infection during pregnancy have been between 30% and 50%. The highest rate of symptomatic congenital infection and sequelae occurs in about 25% of infected infants born of mothers with a primary infection during pregnancy. Symptomatic infants demonstrate a constellation of clinical features that reflect placental dysfunction and probable viral infection of the central nervous system of the fetus. In the United States, we estimate that about 8000 affected infants are born each year. Two options may be available to prevent or treat maternal CMV infection during pregnancy, especially for women with exposure to young children in the home. The first is hygienic intervention. Two studies support the simplicity, harmlessness, and effectiveness of hygienic intervention to prevent child-to-mother transmission of CMV among high-risk pregnant women who know they are susceptible. The second is CMV immunoglobulin. A meta-analysis of 2 clinical trials showed an efficacy of 50% if immunoglobulin is given to pregnant women who have acquired a primary CMV infection during pregnancy. These results mean that seronegative pregnant women have options to prevent fetal infection.

Global pandemic perspectives: public health, mental health, and lessons for the future

Food allergy: Are we getting closer to a cure?

Effect of antibiotic stewardship programs on reduction of antimicrobial resistance in China

Electrocardiographic features of patients with COVID-19: One year of unexpected manifestations

The Lancet Commission on cancer and health systems: harnessing synergies to achieve solutions